The latest staff shakeup at the US Food and Drug Administration to fight COVID-19 will likely make better use of senior career staffers in tackling the pandemic than a plan laid out just a week earlier, experts say.
Center for Drug Evaluation and Research Director Janet Woodcock is moving temporarily to the commissioner’s office so she can be solely focused on Operation Warp Speed, the US effort to facilitate the development, manufacturing and distribution of COVID-19 vaccines, therapeutics and diagnostics
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?